Top Five Symptoms

At Carevive, we believe that understanding cancer symptoms is pivotal to improving the patient experience. In this video transcript, we unveil the top five cancer symptoms reported in our registries.

Topping the list is general pain, closely followed by numbness and tingling, fatigue, nausea, and decreased appetite. These insights gathered from real-world patients provide valuable data for better understanding drug tolerability, especially when compared to clinical trial populations.

Our Carevive Smart Data offers a transformative approach to cancer care, enabling healthcare providers to deliver personalized treatments and support based on comprehensive patient experiences. Reach out to us today to learn more about how our smart data can empower you in providing the best possible care for cancer patients. Together, let’s make a positive impact on cancer care worldwide.

Recent Episodes

The Rothman Index, developed by Dr. Michael Rothman and his brother Steven, is a pioneering patient acuity score designed to help clinicians recognize patient deterioration earlier and more clearly. Presented as an easily understood, color-coded graph that updates in real time, the Index displays upward and downward trends in patient condition at a glance—transforming…

Hospitals collect enormous amounts of clinical data, yet preventable patient decline remains a persistent challenge. Over the past two decades, hospitals have invested heavily in early warning scores and rapid response infrastructure, but translating data into timely, meaningful action has proven difficult. As clinicians contend with alert fatigue and increasing documentation burden, a more…

Healthcare generates enormous volumes of clinical data, yet making sense of that information in real time remains a challenge. Subtle changes in vitals, labs, and nursing assessments often precede serious events, but when that information is fragmented across the medical record, emerging risks can go unnoticed. The central challenge facing hospitals today is not…